U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436130) titled 'Curcumin in Critically Ill Patients With Sepsis' on Feb. 17.
Brief Summary: Sepsis is a life-threatening condition that occurs when the body's response to an infection becomes overwhelming and damages its own organs. It is one of the leading causes of death in critically ill (very sick) patients worldwide. Despite advances in antibiotics, intensive care, and life-support technologies, sepsis remains difficult to treat because much of the harm comes not only from the infection itself, but from an exaggerated and uncontrolled inflammatory response in the body. When a person develops sepsis, the immune system releases large amounts of ...